1. Cell Cycle/DNA Damage
    Epigenetics
  2. HDAC

BML-210 

Cat. No.: HY-19350 Purity: 98.00%
Data Sheet SDS Handling Instructions

BML-210 is the novel HDAC inhibitor, and its mechanism of action has not been characterized.

For research use only. We do not sell to patients.
BML-210 Chemical Structure

BML-210 Chemical Structure

CAS No. : 537034-17-6

Size Price Stock Quantity
10 mM * 1 mL in DMSO $88 In-stock
5 mg $80 In-stock
10 mg $120 In-stock
50 mg $500 In-stock
100 mg   Get quote  
200 mg   Get quote  

* Please select Quantity before adding items.

Customer Review

  • Biological Activity

  • Protocol

  • Technical Information

  • Purity & Documentation

  • References

Description

BML-210 is the novel HDAC inhibitor, and its mechanism of action has not been characterized. IC50 value: 5 μM [1] Target: HDAC4 In vitro: Cell cycle analysis indicated that HeLa cell treatment with 20 and 30 μM concentration of BML-210 increased the proportion of cells in G0/G1 phase, and caused accumulation in subG1, indicating that the cells are undergoing apoptosis [2]. BML-210 inhibits the growth of NB4 cells in dose- and time-dependent manner [3]. In vivo:

References
Molecular Weight

339.43

Formula

C₂₀H₂₅N₃O₂

CAS No.

537034-17-6

Storage
Powder -20°C 3 years
  4°C 2 years
In solvent -80°C 6 months
  -20°C 1 month
Shipping

Room temperature in continental US; may vary elsewhere

Solvent & Solubility

DMSO: ≥ 30 mg/mL

* "<1 mg/mL" means slightly soluble or insoluble. "≥" means soluble, but saturation unknown.

Inquiry Online

Your information is safe with us. * Required Fields.

Product name

 

Salutation

Applicant name *

 

Email address *

Phone number

 

Organization name *

Country *

 

Requested quantity *

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
BML-210
Cat. No.:
HY-19350
Quantity: